Paratek
Developing new treatment options for complex medical issues and providing new technologies to defeat superbugs.
Launch date
Employees
Market cap
CAD174m
Enterprise valuation
CAD470m (Public information from Sep 2023)
Share price
$2.23 PRTK
Boston Massachusetts (HQ)
Financials
Estimates*
| USD | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Revenues | 12.6m | 17.1m | 16.5m | 43.5m | 121m | 151m |
| % growth | - | 36 % | (3 %) | 163 % | 178 % | 25 % |
| EBITDA | (82.0m) | (101m) | (112m) | (73.9m) | (40.7m) | (44.9m) |
| % EBITDA margin | (650 %) | (589 %) | (678 %) | (170 %) | (34 %) | (30 %) |
| Profit | (89.1m) | (112m) | (129m) | (96.5m) | (59.1m) | (63.6m) |
| % profit margin | (706 %) | (656 %) | (778 %) | (222 %) | (49 %) | (42 %) |
| R&D budget | 60.1m | 57.5m | 39.6m | 23.9m | 30.4m | 37.8m |
| R&D % of revenue | 476 % | 336 % | 239 % | 55 % | 25 % | 25 % |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | N/A | IPO | |
$40.0m | Post IPO Equity | ||
| N/A | N/A | IPO | |
N/A | Post IPO Equity | ||
$60.0m | Post IPO Debt | ||
| Total Funding | - | ||
Related Content
Recent News about Paratek
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.